Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
18.08. | BioNexus Gene Lab Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
30.07. | BioNexus Gene Lab Corp - 8-K, Current Report | 1 | SEC Filings | ||
30.07. | BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance-Touted as a new "DeepSeek Moment" in Precision Oncology | 13 | GlobeNewswire (USA) | ||
01.07. | BioNexus Gene Lab Stock Soars 239% | 15 | RTTNews | ||
23.06. | BioNexus Gene Lab Corp - 8-K, Current Report | 10 | SEC Filings | ||
30.04. | BioNexus Gene Lab erlangt NASDAQ-Konformität wieder | 9 | Investing.com Deutsch | ||
30.04. | BioNexus Gene Lab regains Nasdaq compliance | 1 | Investing.com | ||
30.04. | BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness | 231 | GlobeNewswire (Europe) | KUALA LUMPUR, Malaysia, April 30, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC), a biotechnology company specializing in precision diagnostics and specialty chemical solutions, today... ► Artikel lesen | |
BIONEXUS GENE LAB Aktie jetzt für 0€ handeln | |||||
30.04. | BioNexus Gene Lab Corp - 8-K, Current Report | 2 | SEC Filings | ||
29.04. | BioNexus Gene Lab Corp - 10-K/A, Annual Report | 1 | SEC Filings | ||
15.04. | BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory | 210 | GlobeNewswire (Europe) | KUALA LUMPUR, Malaysia, April 15, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) ("BioNexus" or the "Company"), a diversified biotechnology and specialty materials group headquartered... ► Artikel lesen | |
15.04. | BioNexus Gene Lab Corp - 10-K, Annual Report | 1 | SEC Filings | ||
10.04. | BioNexus Gene Lab Corp - 8-K, Current Report | 2 | SEC Filings | ||
07.03. | Krypto-Revolution: BioNexus schreibt Geschichte: Ethereum triumphiert über Bitcoin! | 4.705 | wallstreetONLINE | © Foto: Jakub Porzycki - NurPhotoBioNexus setzt als erstes Nasdaq-Unternehmen auf Ethereum statt Bitcoin und wagt trotz finanzieller Herausforderungen einen kühnen Schritt in die Krypto-Zukunft.Die... ► Artikel lesen | |
06.03. | Krypto-Revolution: Ethereum statt Bitcoin: Nasdaq-Unternehmen BioNexus schreibt Krypto-Geschichte! | 1.093 | wallstreetONLINE | © Foto: Jakub Porzycki - NurPhotoBioNexus setzt als erstes Nasdaq-Unternehmen auf Ethereum statt Bitcoin und wagt trotz finanzieller Herausforderungen einen kühnen Schritt in die Krypto-Zukunft.Die... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
DRAEGERWERK | 64,70 | -1,52 % | Drägerwerk: Experten nehmen Gewinnschätzungen zurück | Im Bereich der Medizintechnik kommt Drägerwerk im ersten Halbjahr beim Auftragseingang auf ein Plus von 15 Prozent. Das dürfte sich im zweiten Halbjahr positiv beim Ergebnis bemerkbar machen. Belastend... ► Artikel lesen | |
SERNOVA BIOTHERAPEUTICS | 0,115 | +5,50 % | Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,792 | +0,76 % | Atossa Therapeutics appoints Janet Rea as SVP of R&D | ||
PING AN HEALTHCARE | 2,004 | -2,72 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor (1833.HK) Reports Solid Interim Results with Steady Revenue and Profit Growth | HONG KONG, Aug. 20, 2025 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (the "Company"; Stock Code: 1833.HK) announced its interim results for the six months ended June... ► Artikel lesen | |
SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharma schließt 'At-the-Market'-Verkaufsvereinbarung über bis zu 2,07 Mio. US-Dollar ab | ||
MOUNTAIN VALLEY MD | 0,011 | -12,31 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
CO-DIAGNOSTICS | 0,290 | -6,45 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
VERU | 3,825 | 0,00 % | These small cap stocks are poised for a comeback - Palisade Capital's Dan Veru | ||
CYTOSORBENTS | 0,812 | +2,65 % | CytoSorbents Corporation: CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR | FDA appeal decision found no issues with DrugSorb-ATR device safety but upheld the De Novo denial, and proposes a potential path forward for market authorization... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update | Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in ChinaGranted orphan drug designation from the European Medicines... ► Artikel lesen | |
VOLITIONRX | 0,635 | 0,00 % | H.C. Wainwright reiterates buy rating on VolitionRX stock at $2.50 | ||
EKSO BIONICS | 5,510 | +4,36 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
IMUNON | 4,440 | -3,90 % | Imunon, Inc.: IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement | LAWRENCEVILLE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the Company... ► Artikel lesen | |
BEYOND AIR | 2,510 | +0,80 % | Beyond Air Signs New International LungFit PH Distribution Agreements, Most Notably in Japan | GARDEN CITY, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial-stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities |